Advances in Cancer Care at Leeds Hospitals

New Technology Introduced at Leeds Cancer Centre

Leeds Teaching Hospitals have recently implemented a new Surface Guided Radiotherapy (SGRT) system at the Leeds Cancer Centre, funded by £600,000 raised through philanthropy. This technology is designed to improve the treatment experience for breast cancer patients by eliminating the need for permanent skin tattoos, which have traditionally been used to guide radiotherapy.

Benefits of Tattoo-less Radiotherapy

The SGRT system enables more precise targeting of radiation, enhancing the accuracy of treatment while also addressing patient comfort and dignity. More than 1,800 breast cancer patients annually are expected to benefit from this innovation. Patients have reported positive experiences with the new approach, appreciating the removal of permanent skin markings.

Philanthropy’s Role in Healthcare Innovation

The introduction of this technology is one example of how charitable donations support advancements in patient care at Leeds Teaching Hospitals. Funding from supporters has also contributed to other initiatives, including the development of healing environments and leadership programmes within the hospital trust.

Summary of Key Points

• £600,000 raised through philanthropy funded the SGRT system.
• More than 1,800 breast cancer patients per year benefit from tattoo-less radiotherapy.
• SGRT improves treatment accuracy and patient comfort.
• Philanthropic support also aids other hospital improvements.

These developments demonstrate ongoing efforts to enhance patient care through technology and compassionate treatment at Leeds Teaching Hospitals.

Source: Leeds Hospitals Charity – The Power of Philanthropy: Autumn 2025